I'm curious as to what some people are going to see if the price doesn't move past 10c come July when the 52 week high drops drastically from .17c to .12.5c or lower. Would the TA alone then present a different mindset towards a run towards its 52 week high? Would the traders view this differently if that was the case?
200 MA (pink) is about to cross the 150 day MA (Yellow) as well (all others crossed now) and the MACD still showing relatively positive. The RSI has downturned back to a lower level (not oversold yet) however today being a rubbish day on the back of the inflation news in the US and still relatively low volume trading doesn't help much.
A couple other things I was curious about:
- Half yearly stated that they have 12+ development contracts currently on the go. Do we know what all these are? Obviously Hologic women's health and the FFN testing, PheCheck (Aptatek) could be another? BDI (Burnet) looking to utilise the Leelu reader? This could expand on comments from the Webinar around FFN and discussions with IR about adding more tests to the Hologic device?
- Revenue increase of 82% driven by Febridx outside US and some initial sales of Viradx US. Just thinking back to the entire financial year previously, total product sales were $300K. Likely that $150K+ of sales for the half was driven by Viradx US?
- Do we know what these manufacturing partnerships are about/with? Is this for new white labelling of febridx to other providers? Similar to Viradx/ and Princeton Bio?
- Are we expecting updates on Viradx studies similar to the Febridx studies, when are these being arranged? Are these primarily Lumos sponsored?
- Product is already CLIA waived. Could give some indication of take up of Febridx once CLIA waiver granted?
- Was Sam Lanyons comments around adding to the 510K clearance with Febridx relating to the CLIA Waiver in the next 6-12 months? Or was he referring about adding Viradx to its own 510K clearance?
- What is this other product? Was he referring to Viradx?
Lumos is also exhibiting at a number of events this calendar year:
(Above is a joint conference with the AMR and Disease prevention and control
A number of events in the US now FDA and EUA received for both products. Might see some good uptake and agreements come into play?
Add to My Watchlist
What is My Watchlist?
